Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by LINDAHL, B.
Right arrow Articles by EVRIN, P.-E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LINDAHL, B.
Right arrow Articles by EVRIN, P.-E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press

research-article

Insulin Resistance Syndrome and Fibrinolytic Activity: The Northern Sweden MONICA Study

BERNT LINDAHL*, KJELL ASPLUND**, MATS ELIASSON{dagger} and PER-ERIC EVRIN{ddagger}

* Department of Nutritional Research and Pathology, University of Umeà S-901 87 Umeà, Sweden.
** Department of Medicine, University Hospital Umeà, Sweden.
{dagger} Department of Medicine, Luleà Hospital Luleà, Sweden.
{ddagger} Department of Clinical Chemistry, Boden Hospital Boden, Sweden.

BACKGROUND: Many studies have, in small and highly selected study populations, described how cardiovascular risk factors tend to cluster in subjects with insulin resistance. Recently, interest has focused on possible relationships between this insulin resistance syndrome and fibrinolysis, and the role of triglycerides in this association. The present study addresses these issues in a general population.

METHODS: A subsample of participants in the population-based Northern Sweden MONICA (MONItoring of trends and determinants in CArdiovascular diseases) Study, consisting of 353 men and 403 women in the 25–64 year age range, was investigated. Insulin resistance was estimated indirectly from the fasting levels of insulin and glucose. Fibrinolytic activity was measured both as plasminogen activator inhibitor type 1 (PAI-1) activity and tissue plasminogen activator (tPA) activity.

RESULTS: Insulin resistance was highly correlated with those cardiovascular risk factors that have been associated with the insulin resistance syndrome, and to the measures of fibrinolytic activity. Subjects in the upper tertile of insulin resistance had a PAI-1 activity that was three times higher than that of the lower third in men and twice as high in women. There was a strong interaction between insulin resistance and serum triglycendes. Low versus high levels of both variables together were associated with a fivefold difference in PAI-1 activity in men and a threefold difference in women. The tPA activity was inversely correlated to both Insulin resistance and serum triglycendes

CONCLUSIONS: In a general population, the ‘Insulin resistance syndrome’ is closely associated with low fibrinolytic activity. Serum triglyceride levels interact with insulin resistance to predict fibrinolytic activity.

Keywords epidemiology, fibrinogen, fibrinolysis, hyperinsulinism, insulin resistance, PAI-1 activity, tPA-activity, tnglycerides

Revised 1 September 1995


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. P. Van Guilder, G. L. Hoetzer, J. J. Greiner, B. L. Stauffer, and C. A. DeSouza
Metabolic syndrome and endothelial fibrinolytic capacity in obese adults
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R39 - R44.
[Abstract] [Full Text] [PDF]


Home page
Scand J Public HealthHome page
Bibliography
Scand J Public Health, October 1, 2003; 31(5): 85 - 91.
[PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. E. Hak, H. A. P. Pols, C. D. A. Stehouwer, J. Meijer, A. J. Kiliaan, A. Hofman, M. M. B. Breteler, and J. C. M. Witteman
Markers of Inflammation and Cellular Adhesion Molecules in Relation to Insulin Resistance in Nondiabetic Elderly: The Rotterdam Study
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4398 - 4405.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Lindahl, B. Dinesen, M. Eliasson, M. Roder, G. Hallmans, and B. Stegmayr
High Proinsulin Levels Precede First-Ever Stroke in a Nondiabetic Population
Stroke, December 1, 2000; 31(12): 2936 - 2941.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. B. Meigs, M. A. Mittleman, D. M. Nathan, G. H. Tofler, D. E. Singer, P. M. Murphy-Sheehy, I. Lipinska, R. B. D'Agostino, and P. W. F. Wilson
Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis: The Framingham Offspring Study
JAMA, January 12, 2000; 283(2): 221 - 228.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
T. G. M. Vrijkotte, L. J. P. van Doornen, and E. J. C. de Geus
Work Stress and Metabolic and Hemostatic Risk Factors
Psychosom Med, November 1, 1999; 61(6): 796 - 805.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. E. Hak, C. D. A. Stehouwer, M. L. Bots, K. H. Polderman, C. G. Schalkwijk, I. C. D. Westendorp, A. Hofman, and J. C. M. Witteman
Associations of C-Reactive Protein With Measures of Obesity, Insulin Resistance, and Subclinical Atherosclerosis in Healthy, Middle-Aged Women
Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1986 - 1991.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. M. Burchfiel, D. S. Sharp, J. D. Curb, B. L. Rodriguez, R. D. Abbott, R. Arakaki, and K. Yano
Hyperinsulinemia and Cardiovascular Disease in Elderly Men : The Honolulu Heart Program
Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 450 - 457.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.